Celcuity Inc. — Investor Relations & Filings
Filings indexed
484
across all filing types
Latest filing
2026-03-26
Annual Report
Country
US
United States of America
Listing
US
CELC
Celcuity Inc. is a clinical-stage biotechnology company focused on developing targeted therapies for multiple solid tumor indications. The company's approach centers on the PI3K/AKT/mTOR (PAM) pathway, a critical signaling cascade involved in cancer cell growth and survival. Its lead product candidate, gedatolisib, is a potential first-in-class, pan-PI3K and mTORC1/2 inhibitor designed to comprehensively blockade the PAM pathway. Celcuity's pipeline is advancing treatments with a focus on breast and prostate cancers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-K - Celcuity Inc. (0001603454) (Filer) | 2026-03-26 | English | |
| SCHEDULE 13D/A - Celcuity Inc. (0001603454) (Subject) | 2026-03-24 | English | |
| SCHEDULE 13G Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| 4 - CELCUITY INC. (0001603454) (Filer) | 2026-02-13 | English | |
| 8-K Filing | 2026-02-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 33047727 | 10-K - Celcuity Inc. (0001603454) (Filer) | 2026-03-26 | English | ||
| 33034993 | SCHEDULE 13D/A - Celcuity Inc. (0001603454) (Subject) | 2026-03-24 | English | ||
| 30852708 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 30852692 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32894939 | 4 - CELCUITY INC. (0001603454) (Filer) | 2026-02-13 | English | ||
| 30852638 | 8-K Filing | 2026-02-12 | English | ||
| 30852627 | SCHEDULE 13G/A Filing | 2026-02-12 | English | ||
| 30852667 | 4 Filing | 2026-01-29 | English | ||
| 30852633 | SCHEDULE 13D/A Filing | 2026-01-16 | English | ||
| 12761760 | Director's Dealing 2026 | 2026-01-09 | English | ||
| 12761759 | S-3ASR | 2026-01-09 | English | ||
|
2025
4 filings
| |||||
| 12761761 | Director's Dealing 2025 | 2025-12-09 | English | ||
| 12761762 | Director's Dealing 2025 | 2025-12-08 | English | ||
| 12761763 | Regulatory Filings 2025 | 2025-12-05 | English | ||
| 12761764 | Director's Dealing 2025 | 2025-12-03 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CHIMERIC THERAPEUTICS LIMITED
Clinical-stage cell therapy company developing CAR T and NK…
|
CHM | AU | Professional, scientific and te… |
|
China National Electric Apparatus Research Institute Co., Ltd.
R&D institution for electrical and electronics testing, equ…
|
688128 | CN | Professional, scientific and te… |
|
Chiome Bioscience Inc.
Clinical-stage biotech company developing antibody-based th…
|
4583 | JP | Professional, scientific and te… |
|
CHITOGENX INC
Clinical stage regenerative medicine company focused on nov…
|
CHGX | CA | Professional, scientific and te… |
|
Chordate Medical Holding AB
Develops a patented, drug-free neuromodulation treatment fo…
|
CMH | SE | Professional, scientific and te… |
|
Chordia Therapeutics,Inc
Clinical-stage biotech developing novel cancer therapies ta…
|
190A | JP | Professional, scientific and te… |
|
Cibus, Inc.
Develops and licenses plant traits using non-GMO precision …
|
CBUS | US | Professional, scientific and te… |
|
Circio Holding ASA
Clinical-stage company developing circular RNA medicines an…
|
CRNA | NO | Professional, scientific and te… |
|
CIZZLE BIOTECHNOLOGY HOLDINGS PLC
A cancer diagnostics developer creating a blood test for ea…
|
CIZ | GB | Professional, scientific and te… |
|
CJ Bioscience
Develops microbiome therapeutics for oncology and IBD using…
|
311690 | KR | Professional, scientific and te… |
Celcuity Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31605/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31605 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31605 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31605 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31605}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Celcuity Inc. (id: 31605)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.